NRIX
Nurix Therapeutics Inc
23.00$
-1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -222.7% | 176.1% | -252.9% | -328.4% | -335.1% | -367.0% | -331.0% | -143.4% | -726.9% | -499.6% | -1,150.3% | -1,067.9% | -798.8% | |
| 18.3% | 24.8% | 23.4% | 33.8% | 32.9% | 32.4% | 22.4% | 11.6% | 63.3% | 34.1% | 60.4% | 42.6% | 46.9% | |
| 45.7% | 52.9% | 47.2% | 73.1% | 69.5% | 64.0% | 47.3% | 23.6% | 123.8% | 66.9% | 150.4% | 125.9% | 107.8% | |
| 39.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -80.1% | 355.4% | -61.6% | -49.1% | -21.5% | 3.4% | -76.0% | -73.7% | 208.5% | -11.4% | 62.3% | -43.1% | 40.6% | |
| 13.3% | 17.1% | 17.4% | 16.0% | 18.6% | 15.8% | 18.9% | 6.1% | 34.3% | 37.8% | 16.7% | 21.4% | 29.4% | |
| 123.3% | -94.8% | 214.1% | -1,083.9% | -169.5% | -1,060.0% | 138.4% | 162.3% | 639.4% | 2.5% | -1,980.6% | 1,028.4% | 54.4% | |
| – | – | – | -0.1% | 0.1% | – | – | 2.8% | 28.2% | – | 25.5% | – | – | |
| 9.2% | 0.0% | 9.8% | 1,966.2% | 363.6% | 1,509.5% | 8.0% | 0.0% | 14.6% | 1,738.3% | 319.5% | 0.7% | 699.6% | |
| -90.2% | 81.3% | -29.0% | 553.9% | -141.0% | 82.5% | -184.7% | 18.9% | -72.9% | 1,241.2% | -2,811.3% | -38.8% | -44.9% | |
| -236.1% | 159.0% | -270.3% | -344.4% | -353.7% | -382.8% | -349.9% | -149.4% | -761.3% | -537.4% | -1,167.0% | -1,089.3% | -828.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.